restor3d Generic Name: restor3d MTP Implant Generic Name: MTP Implant Recall
Generic Name: restor3d MTP Implant Generic Name: MTP Implant Model/Catalog Number: 1103-161620 Software Version: None Product Description: The restor3d Metatarsophalangeal (MTP) Implant is a sterile, single-use implant grade metal device, available in varied articulating surface coverages. The restor3d MTP implant is designed to replace the damaged articulating surface of the first metatarsal distal head. The device is intended for the treatment of patients with degenerative and post-traumatic arthritis in the first metatarsal joint in the presence of good bone stock and integrity of the first metatarsal head. This implant can also be used in the following clinical conditions: hallux valgus or hallux limitus, hallux rigidus, and an unstable or painful metatarsal/phalangeal (MTP) joint. The implant is a single use product intended to be press fit, with optional use of bone cement. The restor3d MTP Implant is comprised of a single laser powder bed fusion (LPBF) printed cobalt-chromium alloy (Co28Cr6Mo) part. The external surface of the implant that is intended to be in contact with the phalanx is mirror polished. Component: Not a component
FDA recall Class II
Ongoing
FDA lists this Class II recall for Generic Name: restor3d MTP Implant Generic Name: MTP Implant. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0264-2027
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Sep 4, 2026
- FDA report date
- Oct 28, 2026
- Quantity in commerce
- 16
- Distribution
- See key details
- FDA cause
- Process change control
What is being recalled?
Generic Name: restor3d MTP Implant Generic Name: MTP Implant Model/Catalog Number: 1103-161620 Software Version: None Product Description: The restor3d Metatarsophalangeal (MTP) Implant is a sterile, single-use implant grade metal device, available in varied articulating surface coverages. The restor3d MTP implant is designed to replace the damaged articulating surface of the first metatarsal distal head. The device is intended for the treatment of patients with degenerative and post-traumatic arthritis in the first metatarsal joint in the presence of good bone stock and integrity of the first metatarsal head. This implant can also be used in the following clinical conditions: hallux valgus or hallux limitus, hallux rigidus, and an unstable or painful metatarsal/phalangeal (MTP) joint. The implant is a single use product intended to be press fit, with optional use of bone cement. The restor3d MTP Implant is comprised of a single laser powder bed fusion (LPBF) printed cobalt-chromium alloy (Co28Cr6Mo) part. The external surface of the implant that is intended to be in contact with the phalanx is mirror polished. Component: Not a component
Affected model & UDI checker
Search the exact identifiers published for Z-0264-2027.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| 1103-161620 | Generic Name: restor3d MTP Implant Generic Name: MTP Implant | Check source notice | 00840097505244 |
FDA code information
Lot Code: Model: 1103-161620 UDI: 00840097505244 Lot: A02979
Why was this product recalled?
Implants were found in the field with orange sterilzation indicators which means implants were not exposed to sterilization.
What actions did restor3d Inc. take?
On 09/21/2026, an "URGENT: MEDICAL DEVICE VOLUNTARY RECALL" Letter was emailed to customers informing them that, Restor3d has identified an error in the sterilization of a lot of large MTP implants (part number 1103-161620) were found in the field with orange sterilization indicators, rather than red, when orange indicates not exposed to sterilization and red indicates exposed to sterilization. Root cause investigation to date indicates that the lot was never sterilized. Customers are instructed to: Do not implant or otherwise use any affected units identified above. Quarantine all affected, unused units identified above and remove them from implant sets, consignment inventory, inventory shelves, and any other storage locations. Complete the attached Field Action Response Form (Attachment A) and return it to restor3d within 10 business days, whether or not affected product is in your possession, so that restor3d can confirm effective distribution of this notice. Package the affected MTP Implants (1103-161620; A02979) to return to restor3d. restor3d has provided a prepaid FedEx shipping label by email for shipment back to 4001 NC-54 Hwy, Suite 2160 Durham, NC 27709. Promptly report to restor3d any patient adverse event, suspected device-related complication, revision surgery, or other clinical concern potentially associated with the affected product. For questions or further assistance - contact Restor3d can be reached at 984-888-0593 or at [email protected].
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0264-2027
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 19, 2026
- openFDA device recall record · Source release Nov 14, 2026 · Retrieved Nov 19, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology